Vatelizumab (Anti-Integrin a2b1 (ITGA2 & ITGB1))

Synonyms: GBR500

Vatelizumab (Anti-Integrin a2b1 (ITGA2 & ITGB1)) is a monoclonal antibody targeting the α2 subunit (CD49b) of very late antigen-2 (VLA-2). It can be used for the research of multiple sclerosis. MW: 144.56 KD.

Vatelizumab (Anti-Integrin a2b1 (ITGA2 & ITGB1))

Purity & Quality Control

≥99

Choose Selective Integrin Inhibitors

Biological Activity

Description Vatelizumab (Anti-Integrin a2b1 (ITGA2 & ITGB1)) is a monoclonal antibody targeting the α2 subunit (CD49b) of very late antigen-2 (VLA-2). It can be used for the research of multiple sclerosis. MW: 144.56 KD.

Product Details

CAS No. 1238217-55-4
Molecular Weight 144.56
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Vatelizumab (Anti-Integrin a2b1 (ITGA2 & ITGB1)) | Vatelizumab (Anti-Integrin a2b1 (ITGA2 & ITGB1)) supplier | purchase Vatelizumab (Anti-Integrin a2b1 (ITGA2 & ITGB1)) | Vatelizumab (Anti-Integrin a2b1 (ITGA2 & ITGB1)) cost | Vatelizumab (Anti-Integrin a2b1 (ITGA2 & ITGB1)) manufacturer | order Vatelizumab (Anti-Integrin a2b1 (ITGA2 & ITGB1)) | Vatelizumab (Anti-Integrin a2b1 (ITGA2 & ITGB1)) distributor